Your browser doesn't support javascript.
loading
Clinicians' Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study.
Vali, Yasaman; Eijk, Roel; Hicks, Timothy; Jones, William S; Suklan, Jana; Holleboom, Adriaan G; Ratziu, Vlad; Langendam, Miranda W; Anstee, Quentin M; Bossuyt, Patrick M M.
Afiliação
  • Vali Y; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Eijk R; Athena Institute, Faculty of Science, VU University Amsterdam, 1081 HV Amsterdam, The Netherlands.
  • Hicks T; NIHR Newcastle In Vitro Diagnostics Co-Operative, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
  • Jones WS; NIHR Newcastle In Vitro Diagnostics Co-Operative, Newcastle upon Tyne Hospitals Foundation Trust, Newcastle upon Tyne NE1 7RU, UK.
  • Suklan J; NIHR Newcastle In Vitro Diagnostics Co-Operative, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
  • Holleboom AG; NIHR Newcastle In Vitro Diagnostics Co-Operative, Newcastle upon Tyne Hospitals Foundation Trust, Newcastle upon Tyne NE1 7RU, UK.
  • Ratziu V; NIHR Newcastle In Vitro Diagnostics Co-Operative, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
  • Langendam MW; NIHR Newcastle In Vitro Diagnostics Co-Operative, Newcastle upon Tyne Hospitals Foundation Trust, Newcastle upon Tyne NE1 7RU, UK.
  • Anstee QM; Department of Internal and Vascular Medicine, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Bossuyt PMM; Assistance Publique-Hôpitaux de Paris, Hôpital Beaujon, University Paris-Diderot, 75013 Paris, France.
J Clin Med ; 11(10)2022 May 11.
Article em En | MEDLINE | ID: mdl-35628838
ABSTRACT
(1)

Background:

Given the high prevalence of non-alcoholic fatty liver disease (NAFLD) and the limitations of liver biopsies, multiple non-invasive tests (NITs) have been developed to identify non-alcoholic fatty liver disease (NAFLD) patients at-risk of progression. The availability of these new NITs varies from country to country, and little is known about their implementation and adoption in routine clinical practice. This study aims to explore barriers and facilitators that influence the adoption of NAFLD NITs, from healthcare professionals' perspectives. (2)

Methods:

A cross-sectional study was performed using an exploratory mixed-methods approach. Twenty-seven clinicians from eight different countries with different specialties filled in our questionnaire. Of those, 16 participated in semi-structured interviews. Qualitative and quantitative data were collected and summarized using the recently published Non-adoption, Abandonment, Scale-up, Spread, and Sustainability (NASSS) framework for new medical technologies in healthcare organizations. (3)

Results:

Several factors were reported as influencing the uptake of NITs for NAFLD in clinical practice. Among those insufficient awareness of tests; lack of practical guidelines and evidence for the performance of tests in appropriate patient populations and care settings; and absence of sufficient reimbursement systems were reported as the most important barriers. Other factors, most notably 'local champions', proper functional payment systems, and sufficient resources in academic hospitals, were indicated as important facilitating factors. (4)

Conclusions:

Clinicians see the adoption of NITs for NAFLD as a complex process that is modulated by several factors, such as robust evidence, practical guidelines, a proper payment system, and local champions. Future research could explore perspectives from other stakeholders on the adoption of NITs.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article